Brokers Issue Forecasts for Landos Biopharma, Inc.'s Q1 2024 Earnings (NASDAQ:LABP)
Landos Biopharma, Inc. (NASDAQ:LABP – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2024 earnings estimates for Landos Biopharma in a research note issued on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will post earnings per share of ($1.12) for the quarter. The consensus estimate for Landos […]